PureTech Health (LON:PRTC) Stock Passes Below Fifty Day Moving Average – Time to Sell?

PureTech Health plc (LON:PRTC)’s share price passed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 140.42 ($1.81) and traded as low as GBX 128.20 ($1.65). PureTech Health shares last traded at GBX 131 ($1.69), with a volume of 186,057 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group reiterated a “buy” rating and issued a GBX 455 ($5.86) price objective on shares of PureTech Health in a research report on Monday, December 16th.

PureTech Health Trading Down 0.3 %

The company has a quick ratio of 2.51, a current ratio of 3.68 and a debt-to-equity ratio of 45.82. The business’s fifty day moving average is GBX 139.83 and its 200 day moving average is GBX 149.92. The stock has a market cap of £382.08 million, a PE ratio of -5.22 and a beta of 1.02.

About PureTech Health

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.